Oct. 20, 2026 — Johnson & Johnson has announced the U.S. launch of its Shockwave C2 Aero Fly Coronary IVL catheter designed to treat a broad range of calcified coronary artery lesions in half the time ...
Nov. 1, 2026 – Abbott has announced the 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular ...
Nov. 2, 2026 – Conavi Medical Corp. has announced the completion of the first U.S. placement and clinical cases with ...
Nov. 1, 2026 — Heartflow, Inc. has announced new landmark randomized clinical data presented at Transcatheter ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Oct. 29, 2026 — Johnson & Johnson has announced 26 presentations featuring the clinical science of Impella heart pumps ...
Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...
Oct. 27, 2026 — Monebo Technologies and Innolitics have announced that the U.S. Food and Drug Administration (FDA) has ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Oct. 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) approval for the Amplatzer Paraclose PVL ...
Oct. 22, 2026 — For patients hospitalized with ischemic stroke and atrial fibrillation (AFib), restoring the heart’s ...
Oct. 26, 2026 — Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Oct. 21, 2026 — Edwards Lifesciences Corp. recently announced that the U.S. Food and Drug Administration (FDA) has ...
Oct. 21, 2026 — The U.S. Food and Drug Administration (FDA) has cleared Elucid's FFR-IQ software for non-invasive ...
Oct. 22, 2026 — Henry Ford Health has performed the first procedures globally in a clinical trial evaluating pulmonary ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Oct. 20, 2026 — Penumbra, Inc. recently announced that the U.S. Food and Drug Administration (FDA) has granted clearance ...
With a sirolimus-based drug-coated balloon (DCBs) entering the U.S. market, interventional cardiologists treating in ...
Oct.19, 2026 – Jupiter Endovascular has announced publication of full results from its SPIRARE II pivotal trial ...
November 03, 2026
